The article

“Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib”
[Cell Physiol Biochem 2018;48:54-62. DOI: 10.1159/000491662]
by Zongsheng Duan, Jing Li, Xiaochuan Pang, Hushan Wang and Zhenbo Su

has been retracted by the current and former Publishers and the Editor.

Following publication, the corresponding author contacted the journal and stated that a replication study did not reproduce the results in the article and requested to retract the article. Concerns were additionally raised about the similarity of Western blot bands within Figure 3B1. When asked to comment on the concerns raised about Figure 3B1 and provide more information about the retraction request, the authors did not respond to our correspondence. The matter was raised to the author's institution who have not responded to correspondence. Given the concerns raised about the data presented in the manuscript, and the author's request to retract the article, the article is being retracted.
The authors did not respond to correspondence about this retraction despite multiple attempts of contact.